Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
New-onset Refractory Status Epilepticus (NORSE)
100%
Cerebral Small Vessel Disease (cSVD)
70%
Oxygen Extraction Fraction
47%
White Matter Hyperintensities
44%
Interim Analysis
40%
Retinocochleocerebral Vasculopathy
40%
Status Epilepticus
38%
Cognitive Dementia
36%
Systemic Manifestations
36%
Vascular Cognitive Impairment
36%
Neuroimaging
35%
Fluid-attenuated Inversion Recovery (FLAIR)
34%
Cerebral Blood Flow
31%
Febrile Infection-related Epilepsy Syndrome (FIRES)
30%
Comparative Analysis
24%
Odds Ratio
23%
Vascular Dementia
23%
Monogenic
23%
Etiology
23%
Quality of Life
22%
Seizure
22%
Disease Biomarkers
21%
Disease Progression
21%
Imaging Biomarkers
21%
Amyloid Deposition
20%
Critical Care Neurology
20%
Creutzfeldt-Jakob Disease
20%
Sleep Pathology
20%
Neurological Manifestations
20%
PiB-PET
20%
Multimodal Neuroimaging
20%
Cerebrovascular Physiology
20%
Neuroimaging Techniques
20%
Emergency Neurology
20%
Neuroinflammation
20%
Alzheimer's Disease
20%
Alzheimer's Dementia
20%
Critical Illness
20%
Binding Potential
20%
Metabolism
20%
White Matter Injury
20%
Metabolic Stress
20%
Patient Management
20%
Fever
20%
Therapeutic Monoclonal Antibody
20%
Neurodegeneration
20%
Microvasculopathy
20%
Trends in Management
20%
Therapeutic Challenges
20%
Neurology/neurologic
20%
Neuroscience
Status Epilepticus
80%
Cerebrovascular Disease
70%
Cognitive Disorders
48%
Ischemia
46%
Amyloid Protein
40%
Vascular Disease
40%
Leukoencephalopathy
40%
Biological Marker
39%
Magnetic Resonance Imaging
35%
Epilepsy
30%
Vascular Dementia
23%
Alzheimer's Disease
22%
Quality of Life
22%
Dysautonomia
20%
Creutzfeldt Jakob Disease
20%
Parkinson's Disease
20%
Neurodegeneration
20%
Hydrocephalus
20%
Subarachnoid Hemorrhage
20%
Monoclonal Antibody
20%
Cognitive Change
20%
Metabolic Pathway
20%
Brain Injury
20%
Polysomnography
16%
Spin Echo
13%
Neurofilament Light Chain
13%
Diffusion Tensor Imaging
13%
Risk Factor
12%
Rapid Eye Movement Sleep
12%
Arterial Spin Labeling
11%
Cognitive Decline
8%
Limb Movement
8%
Neurodegenerative Disorder
8%
Olfaction
6%
Non-Motor Symptoms
6%
Cerebrovascular Accident
6%
Montreal Cognitive Assessment
6%
Antiseizure Medication
5%
Magnetic Resonance Imaging of Brain
5%
Nervous System Disorder
5%
Positron Emission Tomography
5%
Clinical Neurophysiology
5%